S
ANGO icon

SignatureFD’s AngioDynamics ANGO Stock Holding History

SignatureFD’s Portfolio ANGO Stock Details ANGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-602
Closed -$4.68K – 3311
2024
Q3 		$4.68K Buy
+602
New +$4.35K ﹤0.01% 2592
2023
Q4 		– Sell
-1,002
Closed -$7.33K – 3131
2023
Q3 		$7.33K Buy
1,002
+949
+1,791% +$7.9K ﹤0.01% 2357
2023
Q2 		$553 Buy
+53
New +$510 ﹤0.01% 3060
2022
Q4 		– Sell
-138
Closed -$3K – 3288
2022
Q3 		$3K Buy
+138
New +$3.03K ﹤0.01% 2602
2020
Q3 		– Sell
-510
Closed -$5K – 2595
2020
Q2 		$5K Buy
+510
New +$5.26K ﹤0.01% 1771
2020
Q1 		– Sell
-71
Closed -$1K – 2280
2019
Q4 		$1K Buy
+71
New +$1.08K ﹤0.01% 1985

Other funds holding ANGO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SFM
Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
SBH
Segall Bryant & Hamill Chicago, Illinois $6.98B AUM 34.78% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

SignatureFD's ANGO Position: Q4 2024 in Review

SignatureFD sold out of AngioDynamics (ANGO) in Q4 2024, closing a stake of 602 shares — an estimated $4.68K sold.

SignatureFD first reported a position in ANGO in Q4 2019 and held it in 6 quarters. The position peaked at $7.33K in Q3 2023. 135 funds tracked by Wall St. Rank hold ANGO as of Q4 2024.

  • SignatureFD reported no remaining AngioDynamics position as of Q4 2024 after selling out during the quarter.
  • SignatureFD sold 602 AngioDynamics shares in Q4 2024, an estimated $4.68K.
  • SignatureFD first reported a position in AngioDynamics in Q4 2019 and held it in 6 quarters.
  • SignatureFD's AngioDynamics position peaked at $7.33K in Q3 2023.
  • 135 funds tracked by Wall St. Rank held AngioDynamics as of Q4 2024.

Based on SignatureFD's 13F filing for Q4 2024, filed 10 Feb 2025.